Dermaliq&s;s mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Business Model:
Revenue: $0
Employees: 0-0
Address: 1209, Orange St.
City: Wilmington
State: DE
Zip: 19801
Country: US
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The proprietary technology now owned by Dermaliq, called hyliQ™, is designed to allow cutaneous drug delivery with bioavailability. The technology enables the development of effective liquid drug products with exceptional cosmetic properties.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Series A | $0 |
3E Bioventures Beijing Whale Technology Corporation 3E Bioventures Beijing Whale Technology Corporation |
1/2022 | Series A | 2 | $15M |
3E Bioventures Capital Beijing Whale Technology Corporation Ltd 3E Bioventures Beijing Whale Technology Corporation |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|